Werkgroep Cardiologische centra Nederland

CRD-750-202 (Recruiting)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Effectiveness of CRD-750 in Subjects with Chronic Heart Failure with Preserved Ejection Fraction
Medicine
Tovinontrine
Population
Heart failure
Phase
II
Starting year
2023

Director of Study

drs. N.Y.Y. AL Windy (Cardioloog)
Zutphen, Gelre Ziekenhuizen